June 18, 2024

The Rising Demand For Organ Donation Is Driving The Tissue And Organ Transplantation Market

With the rising prevalence of chronic diseases and organ failures, there has been an increasing demand for tissue and organ transplantation procedures. Tissue and organ transplantation involves surgically removing an organ or tissue from one person (donor) and placing it in another person (recipient). Some of the commonly transplanted tissues and organs include kidneys, liver, heart, lungs, pancreas, intestine, skin, and corneas. These procedures help replace damaged or failed organs and tissues, thereby improving the quality of life of patients with end-stage organ failures. According to the latest estimates, over 114,000 adults and children in the United States are currently on the waitlist for organ transplantation.

The global Tissue And Organ Transplantation Market is estimated to be valued at Us$ 20.8 Bn in 2024 and is expected to exhibit a CAGR Of 7.9% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends in the tissue and organ transplantation market is the rising adoption of stem cell therapy. Mesenchymal stem cells derived from tissues such as bone marrow, adipose tissue, placenta, and umbilical cord blood are being investigated for their therapeutic potential in regeneration of damaged tissues and organs. Preclinical and clinical studies have demonstrated the safety and efficacy of stem cells in reducing organ dysfunction and injury. For instance, mesenchymal stem cells show immune-modulating properties and tissue regeneration effects, thereby finding increasing application in the treatment of various chronic conditions including liver disease, COPD, diabetes, and cancers. This is expected to present lucrative opportunities for players operating in the tissue and organ transplantation market over the forecast period.

Porter’s Analysis

Threat of new entrants: The tissue and organ transplantation market requires huge capital investment for research and development of new transplantation techniques. Strict regulations by the government healthcare bodies also pose significant entry barriers.

Bargaining power of buyers: The demand for transplantation is inelastic in nature as it deals with life saving procedures. However, the high cost of transplantation procedures increases the bargaining power of buyers.

Bargaining power of suppliers: Major suppliers for this market are hospitals, transplant centers, donor networks and pharmaceutical companies. The complex supply chain involved increases the bargaining power of suppliers.

Threat of new substitutes: There exist no close substitutes for tissues and organs. However, advances in regenerative medicines and 3D bioprinting of tissues and organs pose a potential long term threat of substitution.

Competitive rivalry: The market comprises large multinational players and rising regional players. Intense competition exists to develop innovative transplantation techniques and solutions to gain higher market share.

Key Takeaways

The Global Tissue And Organ Transplantation Market Demand is expected to witness high growth over the forecast period supported by rising prevalence of chronic diseases and increasing aging population. The global Tissue and Organ Transplantation Market is estimated to be valued at US$ 20.8 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024 to 2031.

Regional analysis:

 

North America dominates the market currently due to favorable reimbursement policies and accessibility to transplantation procedures. Asia Pacific is expected to grow at the fastest pace owing to greater focus on improving health outcomes, rising medical tourism and increasing healthcare expenditure in countries like China and India.

Key players:

 

Key players operating in the tissue and organ transplantation market are Probi AB, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, Probiotics International Limited (Protexin), UAS Laboratories LLC. These players are focusing on new product launches and strategic collaborations to strengthen their market position.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it